22 November 2017
News and Views
Links and Services
The latest issue of the Annals of Internal Medicine evaluates combination therapy with telaprevir for chronic Hepatitis C virus genotype 1 infection in patients with HIV.
Telaprevir plus peginterferon-α2a (PEG-IFN-α2a) and ribavirin substantially increases t
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors